These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition. Yang Z; Wu D; Chen Y; Min Z; Quan Y Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022 [TBL] [Abstract][Full Text] [Related]
3. BMAL1 knockdown triggers different colon carcinoma cell fates by altering the delicate equilibrium between AKT/mTOR and P53/P21 pathways. Zhang Y; Devocelle A; Souza L; Foudi A; Tenreira Bento S; Desterke C; Sherrard R; Ballesta A; Adam R; Giron-Michel J; Chang Y Aging (Albany NY); 2020 May; 12(9):8067-8083. PubMed ID: 32388500 [TBL] [Abstract][Full Text] [Related]
4. Silencing of E-cadherin expression leads to increased chemosensitivity to irinotecan and oxaliplatin in colorectal cancer cell lines. Skarkova V; Skarka A; Manethova M; Stefanidi AA; Rudolf E Hum Exp Toxicol; 2021 Dec; 40(12):2063-2073. PubMed ID: 34075792 [TBL] [Abstract][Full Text] [Related]
5. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers. Gavert N; Vivanti A; Hazin J; Brabletz T; Ben-Ze'ev A Mol Cancer Res; 2011 Jan; 9(1):14-24. PubMed ID: 21123622 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of astrocyte elevated gene-1 (AEG-1) in cervical cancer cells decreases their invasiveness, epithelial to mesenchymal transition, and chemoresistance. Liu X; Wang D; Liu H; Feng Y; Zhu T; Zhang L; Zhu B; Zhang Y Cell Cycle; 2014; 13(11):1702-7. PubMed ID: 24675891 [TBL] [Abstract][Full Text] [Related]
7. BMAL1 promotes colorectal cancer cell migration and invasion through ERK- and JNK-dependent c-Myc expression. Shan L; Zheng W; Bai B; Hu J; Lv Y; Chen K; Wang X; Pan Y; Huang X; Zhu H; Dai S Cancer Med; 2023 Feb; 12(4):4472-4485. PubMed ID: 36806631 [TBL] [Abstract][Full Text] [Related]
8. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition. Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728 [TBL] [Abstract][Full Text] [Related]
9. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion. Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741 [TBL] [Abstract][Full Text] [Related]
10. Suppression of colorectal cancer metastasis by nigericin through inhibition of epithelial-mesenchymal transition. Zhou HM; Dong TT; Wang LL; Feng B; Zhao HC; Fan XK; Zheng MH World J Gastroenterol; 2012 Jun; 18(21):2640-8. PubMed ID: 22690072 [TBL] [Abstract][Full Text] [Related]
11. S100A6 mediated epithelial-mesenchymal transition affects chemosensitivity of colorectal cancer to oxaliplatin. Zhang C; Zeng M; Xu Y; Huang B; Shi P; Zhu X; Cao Y Gene; 2024 Jul; 914():148406. PubMed ID: 38521111 [TBL] [Abstract][Full Text] [Related]
12. NKX6.1 Represses Tumorigenesis, Metastasis, and Chemoresistance in Colorectal Cancer. Chung HH; Lee CT; Hu JM; Chou YC; Lin YW; Shih YL Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707737 [TBL] [Abstract][Full Text] [Related]
13. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Yang AD; Fan F; Camp ER; van Buren G; Liu W; Somcio R; Gray MJ; Cheng H; Hoff PM; Ellis LM Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4147-53. PubMed ID: 16857785 [TBL] [Abstract][Full Text] [Related]
14. The Role of Cyanidin-3- Kurter H; Basbinar Y; Ellidokuz H; Calibasi-Kocal G Nutrients; 2023 Nov; 15(22):. PubMed ID: 38004099 [TBL] [Abstract][Full Text] [Related]
15. miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα. Xin H; Wang C; Liu Z BMC Cancer; 2019 Jan; 19(1):30. PubMed ID: 30621631 [TBL] [Abstract][Full Text] [Related]
16. ARID1A regulates E-cadherin expression in colorectal cancer cells: a promising candidate therapeutic target. Erfani M; Zamani M; Hosseini SY; Mostafavi-Pour Z; Shafiee SM; Saeidnia M; Mokarram P Mol Biol Rep; 2021 Oct; 48(10):6749-6756. PubMed ID: 34424445 [TBL] [Abstract][Full Text] [Related]
17. Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 Axis. Rokavec M; Bouznad N; Hermeking H Cell Mol Gastroenterol Hepatol; 2019; 7(4):783-802. PubMed ID: 30831320 [TBL] [Abstract][Full Text] [Related]
18. Role of mitochondrial function in the invasiveness of human colon cancer cells. Lin CS; Liu LT; Ou LH; Pan SC; Lin CI; Wei YH Oncol Rep; 2018 Jan; 39(1):316-330. PubMed ID: 29138850 [TBL] [Abstract][Full Text] [Related]
19. Colon cancer at the molecular level--usefulness of epithelial-mesenchymal transition analysis. Todosi AM; Gavrilescu MM; Aniţei GM; Filip B; Scripcariu V Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1106-11. PubMed ID: 23700897 [TBL] [Abstract][Full Text] [Related]
20. Influence of the Twist gene on the invasion and metastasis of colon cancer. Wang D; Rai B; Qi F; Liu T; Wang J; Wang X; Ma B Oncol Rep; 2018 Jan; 39(1):31-44. PubMed ID: 29115546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]